Cargando…
Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study
BACKGROUND: The regulation of fibroblast growth factor-23 (FGF23) secretion in patients with chronic kidney disease (CKD) is incompletely understood. An in vitro study showed that metabolic acidosis increased FGF23 in mouse bone. The objective of this study is to evaluate the effect of oral sodium b...
Autores principales: | Chen, Wei, Melamed, Michal L., Hostetter, Thomas H., Bauer, Carolyn, Raff, Amanda C., Almudevar, Anthony L., Lalonde, Amy, Messing, Susan, Abramowitz, Matthew K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974735/ https://www.ncbi.nlm.nih.gov/pubmed/27495287 http://dx.doi.org/10.1186/s12882-016-0331-6 |
Ejemplares similares
-
Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults
por: Abramowitz, Matthew K., et al.
Publicado: (2012) -
The serum anion gap is altered in early kidney disease and associates with mortality
por: Abramowitz, Matthew K., et al.
Publicado: (2012) -
Fibroblast growth factor 23 and tubular sodium handling in young patients with incipient chronic kidney disease
por: Freundlich, Michael, et al.
Publicado: (2019) -
Defining Acid-Base Status in Hemodialysis: Is Bicarbonate Enough?
por: Abramowitz, Matthew K.
Publicado: (2020) -
Bicarbonate of Sodium in Iodoform Poisoning
Publicado: (1885)